Dr. Stephen Farrow, trained in medicine, endocrinology, and geriatrics, was a physician-investigator with Detroit’s Wayne State University. He also studied at the National Institutes of Health in Bethesda and trained at and conducted research with the University of Michigan in Ann Arbor. He served with Wayne’s faculty until 2005, when he relocated to the U.S. Gulf Coast. He rejoined Wayne in 2022 as adjunct professor of medicine and endocrinology to provide patient consultation and clinical education and to conduct community-based research. He studied executive business at Vanderbilt and with the American Association for Physician Leadership. Additionally, he completed executive fellowships with the VA and the Office of Personnel Management. His three decade’s service with the VA included patient care, clinical and military human performance research, and teaching. His VACO Veterans Affairs Central Office—funded initiatives included an original algorithm for cancer evaluation tracking and a novel electronic health record clinician review accelerator now in use at 30 VA medical centers. He was founding medical director for the VA enterprise Locum tenens program, and he implemented the U.S. Department of Veterans Affairs (VA) and Department of Health and Human Services partnership which brought Public Health Service (formerly Marine Medical Service) Commissioned Corps physicians to VA clinical service for the first time. In 1995, Dr. Farrow formalized the 501c3 Community Health & Hypertension Research Education and Screening Team (CHHREST). CHHREST worked with Detroit residents who were apprehensive about clinical trials to teach them about cardiovascular risk, how clinical research helps improve our ability to manage disease, and how to safely participate in research studies. CHHREST worked with the American Heart Association, the Michigan Department of Public Health, the Detroit VA Medical Center, Wayne’s medical school, and professional and student groups to launch Michigan’s Blood Pressure Sunday mass screening program. He established the accredited Urban Hypertension Update to provide a unique clinical perspective on the relation between select organ systems and urban cardiovascular disease. His work with CHHREST earned the VA’s Provider-of-Choice and Multicultural Workplace awards, and CHHREST was a featured topic at the NIH’s 2003 Pan-American Hypertension Initiative conference. In 2020, Dr. Farrow became executive director for the 501c3 National Diabetes & Obesity Research Institute (NDORI). A state-public-private initiative based in Mississippi, NDORI is building an expanding partnership framework to prevent, mitigate, and cure diabetes and obesity-related disease. NDORI provides remote consultation to the underserved Delta region, and NDORI’s clinical trials program facilitates underrepresented group participation in new-drug validation research. Each year, NDORI sponsors an accredited clinician summit and undergraduate research competition on diabetes and obesity. Dr. Farrow serves as a mentor for William Carey University osteopathic medicine students who conduct diabetes screening and case-finding at faith and other community venues. Dr. Farrow is treasurer for the Diabetes Coalition of Mississippi and physician co-chair for Mississippi’s Obesity Task Force where he helps implement state-wide access to the Diabetes Prevention Program, expand nutrition-security tracking, and increase health promotion activities for youth. In 2022, Dr. Farrow received the American Association for Clinical Endocrinology’s International Award for Outstanding Promotion of Endocrinology Service to the Underserved.